ATE178209T1 - Pharmazeutische flüssige suspensionszusammensetzung mit kontrollierter freigabe - Google Patents
Pharmazeutische flüssige suspensionszusammensetzung mit kontrollierter freigabeInfo
- Publication number
- ATE178209T1 ATE178209T1 AT93119587T AT93119587T ATE178209T1 AT E178209 T1 ATE178209 T1 AT E178209T1 AT 93119587 T AT93119587 T AT 93119587T AT 93119587 T AT93119587 T AT 93119587T AT E178209 T1 ATE178209 T1 AT E178209T1
- Authority
- AT
- Austria
- Prior art keywords
- naproxen
- administration
- controlled release
- liquid suspension
- suspension composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI922826A IT1256651B (it) | 1992-12-11 | 1992-12-11 | Composizione farmaceutica a rilascio controllato in sospensione liquida |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE178209T1 true ATE178209T1 (de) | 1999-04-15 |
Family
ID=11364448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93119587T ATE178209T1 (de) | 1992-12-11 | 1993-12-06 | Pharmazeutische flüssige suspensionszusammensetzung mit kontrollierter freigabe |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0601508B1 (de) |
| JP (1) | JPH06279274A (de) |
| AT (1) | ATE178209T1 (de) |
| DE (1) | DE69324214T2 (de) |
| ES (1) | ES2132163T3 (de) |
| IT (1) | IT1256651B (de) |
| SG (1) | SG54207A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1270216B (it) * | 1994-06-14 | 1997-04-29 | Recordati Chem Pharm | Metodo di stabilizzazione di composti biologicamente attivi mediante microgranuli ricoperti sospendibili in fluidi alimentari |
| GB9611328D0 (en) * | 1996-05-31 | 1996-08-07 | Zeneca Ltd | Pharmaceutical compositions |
| DE19648576C2 (de) | 1996-11-23 | 1999-08-12 | Lohmann Therapie Syst Lts | Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt |
| IL128043A (en) * | 1997-05-30 | 2004-08-31 | Osmotica Corp | Multi-layered osmotic device for controlled delivery of active agents |
| SE9903879D0 (sv) * | 1999-10-28 | 1999-10-28 | Ethical Pharmaceuticals Sweden | Multipor food protection |
| FR2822834B1 (fr) | 2001-04-02 | 2005-02-25 | Flamel Tech Sa | Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation |
| US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| FR2837100B1 (fr) * | 2002-03-18 | 2004-07-23 | Flamel Tech Sa | Comprimes a bases de microcapsules a liberation modifiee |
| FR2843881B1 (fr) * | 2002-09-02 | 2006-06-02 | Flamel Tech Sa | Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s) |
| ATE407674T1 (de) | 2002-04-09 | 2008-09-15 | Flamel Tech Sa | Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin |
| DE60325709D1 (de) | 2002-04-09 | 2009-02-26 | Flamel Tech Sa | Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen |
| FR2843117B1 (fr) | 2002-07-30 | 2004-10-15 | Flamel Tech Sa | Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques |
| FR2860516B1 (fr) | 2003-10-03 | 2006-01-13 | Flamel Tech Sa | Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques |
| FR2862536B1 (fr) | 2003-11-21 | 2007-11-23 | Flamel Tech Sa | Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques |
| EP1765305A4 (de) * | 2004-07-09 | 2008-06-04 | Drugtech Corp | Kontrollierte phasenzusammensetzungstechnologie als verbessertes verfahren zum schutz von arzneimitteln |
| US20180104197A9 (en) | 2014-05-01 | 2018-04-19 | Sun Pharmaceutical Industries Limited | Extended release liquid compositions of metformin |
| US10258583B2 (en) * | 2014-05-01 | 2019-04-16 | Sun Pharmaceutical Industries Limited | Extended release liquid compositions of guanfacine |
| US9962336B2 (en) | 2014-05-01 | 2018-05-08 | Sun Pharmaceutical Industries Limited | Extended release suspension compositions |
| WO2015166473A1 (en) | 2014-05-01 | 2015-11-05 | Sun Pharmaceutical Industries Limited | Extended release suspension compositions |
| EP3174515A4 (de) | 2014-07-30 | 2018-03-21 | Sun Pharmaceutical Industries Limited | Verpackung mit zwei kammern |
| US10238803B2 (en) | 2016-05-02 | 2019-03-26 | Sun Pharmaceutical Industries Limited | Drug delivery device for pharmaceutical compositions |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4571333A (en) * | 1983-06-14 | 1986-02-18 | Syntex (U.S.A.) Inc. | Controlled release naproxen and naproxen sodium tablets |
| EP0178299A4 (de) * | 1984-03-21 | 1987-04-28 | Key Pharma | Dosierungsform für naproxyn für dauerverabreichung im mund. |
| IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| IT1231410B (it) * | 1987-09-22 | 1991-12-04 | Cooperativa Farmaceutica | Composizione farmaceutica antiinfiammatoria ad effetto prolungato per uso topico |
| GB8724763D0 (en) * | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
| IT1226940B (it) * | 1988-09-16 | 1991-02-22 | Recordati Chem Pharm | Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide |
| IE902829A1 (en) * | 1989-08-14 | 1991-02-27 | Eurand America | Microencapsulated taste-masked water-insoluble nsaid drug¹materials |
| IE66933B1 (en) * | 1990-01-15 | 1996-02-07 | Elan Corp Plc | Controlled absorption naproxen formulation for once-daily administration |
-
1992
- 1992-12-11 IT ITMI922826A patent/IT1256651B/it active IP Right Grant
-
1993
- 1993-12-06 SG SG1996004299A patent/SG54207A1/en unknown
- 1993-12-06 AT AT93119587T patent/ATE178209T1/de not_active IP Right Cessation
- 1993-12-06 DE DE69324214T patent/DE69324214T2/de not_active Expired - Fee Related
- 1993-12-06 EP EP93119587A patent/EP0601508B1/de not_active Expired - Lifetime
- 1993-12-06 ES ES93119587T patent/ES2132163T3/es not_active Expired - Lifetime
- 1993-12-10 JP JP5310680A patent/JPH06279274A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE69324214T2 (de) | 1999-08-19 |
| DE69324214D1 (de) | 1999-05-06 |
| EP0601508A2 (de) | 1994-06-15 |
| ITMI922826A1 (it) | 1994-06-11 |
| EP0601508A3 (en) | 1995-10-25 |
| JPH06279274A (ja) | 1994-10-04 |
| EP0601508B1 (de) | 1999-03-31 |
| SG54207A1 (en) | 1998-11-16 |
| IT1256651B (it) | 1995-12-12 |
| ES2132163T3 (es) | 1999-08-16 |
| ITMI922826A0 (it) | 1992-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE178209T1 (de) | Pharmazeutische flüssige suspensionszusammensetzung mit kontrollierter freigabe | |
| AU6764390A (en) | Pharmaceutical granules and drug dosage units made therefrom | |
| MY125662A (en) | Pharmaceutical formulations containing darifenacin | |
| DE68907762D1 (de) | Arzneizubereitung mit gesteuerter wirkstofffreisetzung und verfahren zu deren herstellung. | |
| EP0347024A3 (en) | Aqueous emulsion coating for pharmaceutical dosage form | |
| ATE202473T1 (de) | Rasch freisetzende tablettenkerne mit unlöslichen arzneistoffen und mit einem retardüberzug | |
| ATE246505T1 (de) | Zubereitung enthaltend cefaclor oder cephalexin mit modifizierter freisetzungsmatrix | |
| DE69638364D1 (de) | Formulierungen mit kontrollierter abgabe (albuterol) | |
| FI930906A0 (fi) | Laekemedelsfrigoeringssystem foer minocyklin, vilket frigoer laekemedel stoetvis och aer avsedda foer administrering en gaong per dag | |
| DK0754452T3 (da) | Farmaceutisk præparat i form af en overtrukket kapsel, der frigives i den nedre del af fordøjelsessystemet | |
| AU4368797A (en) | Controlled-release formulations coated with aqueous dispersions of ethylcellulose | |
| WO1994027557A3 (en) | Pharmaceutical thermal infusion process | |
| ES2171469T3 (es) | Composicion administrada por via nasal y preparacion que la contiene. | |
| DE3856258D1 (de) | Verfahren zur Herstellung eines Retardpräparates, das Diltiazem in einer einzigen Tagesdosis enthält | |
| DE69008107D1 (de) | Zubereitung mit verzögerter Freigabe eines Hydrochlorids eines basischen Arzneistoffs. | |
| DE69301742D1 (de) | Darreichungsformen mit verlaengerter Wirkstoffreigabe | |
| ATE110564T1 (de) | Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren. | |
| MY114610A (en) | Controlled drug delivery system for diltiazem. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |